Ovarian Cancer Treatment in Istanbul: Expert Gynecologic Onkologiya

MedTravelExpertise — Etibar etdiyiniz sağlamlıq tərəfdaşınız

Bu gün pulsuz fərdi təklifinizi alın

Xüsusi xəstə koordinatoru ilə danışın — pulsuz məsləhət, öhdəliksiz, həftənin 7 günü çoxdilli dəstək.

💬 Pulsuz təklif üçün WhatsApp-da yazın

Istanbul's JCI-accredited gynecologic oncology centers offer comprehensive ovarian cancer treatment — from cytoreductive surgery and carboplatin-paclitaxel chemotherapy to PARP inhibitors and HIPEC — at 60-75% lower cost than the ölkəniz, following ESMO and NCCN guidelines.

📋

Free Treatment Guide PDF

Costs, clinics, recovery timelines and what to ask your surgeon.

How much does ovarian cancer treatment cost in Istanbul?

Cytoreductive surgery costs $10,000–$20,000 in Istanbul versus €X.XXX–€XX.XXX in the ölkəniz. Carboplatin-paclitaxel (6 cycles) costs $8,000–$15,000 versus €X.XXX–€XX.XXX Olaparib maintenance costs $3,000–$5,000/month versus €X.XXX–€XX.XXX/month. Total treatment cost for stage III ovarian cancer is typically $25,000–$50,000 in Istanbul versus €X.XXX–€XX.XXX in the ölkəniz.

Cytoreductive surgery: primary and interval debulking

Save Up to 70% Compared to Western Prices

See How Much You Could Save

Compare our JCI-accredited partner hospital rates against your home country pricing — completely free of charge.

💬 Compare My Savings on WhatsApp

The goal of cytoreductive surgery is to remove as much tumor as possible. Istanbul's gynecologic oncologists perform primary debulking surgery (before chemotherapy) and interval debulking surgery (after neoadjuvant chemotherapy). Optimal debulking — leaving no visible residual disease — is associated with significantly better survival.

Chemotherapy: carboplatin-paclitaxel and bevacizumab

The standard first-line chemotherapy for ovarian cancer is carboplatin-paclitaxel (6 cycles, every 3 weeks). Bevacizumab (Avastin) is added for high-risk patients. For platinum-resistant relapse, Istanbul centers offer pegylated liposomal doxorubicin, gemcitabine, and topotecan.

PARP inhibitors for BRCA-mutated ovarian cancer

BRCA1/2 testing is performed for all ovarian cancer patients in Istanbul. BRCA-mutated patients are eligible for PARP inhibitor maintenance therapy after platinum-based chemotherapy. Olaparib reduces the risk of relapse by 70% in BRCA-mutated patients. Istanbul centers offer olaparib, niraparib, and rucaparib at 60-65% lower cost than the ölkəniz.

How to start ovarian cancer treatment in Istanbul

Send your pathology report, CT scan, CA-125 and HE4 tumor markers, and BRCA testing results to our coordination team. Istanbul's gynecologic oncology tumor board will review your case and provide a treatment plan within 48-72 hours.

MedTravelExpertise — JCI-Accredited Hospital Network

Ready to Take the Next Step?

Our multilingual team is available 7 days a week. No obligation, just expert guidance tailored to your needs.

💬 Start Your Free Consultation on WhatsApp